Department of Spine Surgery, Third Xiangya Hospital, Central South University, Changsha, China.
Department of Orthopedics, Third Hospital of Changsha, Changsha, China.
Front Immunol. 2024 Apr 2;15:1362970. doi: 10.3389/fimmu.2024.1362970. eCollection 2024.
BACKGROUND: T cell exhaustion in the tumor microenvironment has been demonstrated as a substantial contributor to tumor immunosuppression and progression. However, the correlation between T cell exhaustion and osteosarcoma (OS) remains unclear. METHODS: In our present study, single-cell RNA-seq data for OS from the GEO database was analysed to identify CD8+ T cells and discern CD8+ T cell subsets objectively. Subgroup differentiation trajectory was then used to pinpoint genes altered in response to T cell exhaustion. Subsequently, six machine learning algorithms were applied to develop a prognostic model linked with T cell exhaustion. This model was subsequently validated in the TARGETs and Meta cohorts. Finally, we examined disparities in immune cell infiltration, immune checkpoints, immune-related pathways, and the efficacy of immunotherapy between high and low TEX score groups. RESULTS: The findings unveiled differential exhaustion in CD8+ T cells within the OS microenvironment. Three genes related to T cell exhaustion (RAD23A, SAC3D1, PSIP1) were identified and employed to formulate a T cell exhaustion model. This model exhibited robust predictive capabilities for OS prognosis, with patients in the low TEX score group demonstrating a more favorable prognosis, increased immune cell infiltration, and heightened responsiveness to treatment compared to those in the high TEX score group. CONCLUSION: In summary, our research elucidates the role of T cell exhaustion in the immunotherapy and progression of OS, the prognostic model constructed based on T cell exhaustion-related genes holds promise as a potential method for prognostication in the management and treatment of OS patients.
背景:在肿瘤微环境中,T 细胞耗竭已被证明是肿瘤免疫抑制和进展的一个重要因素。然而,T 细胞耗竭与骨肉瘤(OS)之间的相关性尚不清楚。
方法:在本研究中,我们分析了 GEO 数据库中 OS 的单细胞 RNA-seq 数据,以鉴定 CD8+T 细胞并客观地区分 CD8+T 细胞亚群。然后使用亚群分化轨迹来确定对 T 细胞耗竭有反应的基因。随后,应用六种机器学习算法来开发与 T 细胞耗竭相关的预后模型。该模型随后在 TARGETs 和 Meta 队列中进行了验证。最后,我们检查了高和低 TEX 评分组之间免疫细胞浸润、免疫检查点、免疫相关途径和免疫治疗效果的差异。
结果:研究结果揭示了 OS 微环境中 CD8+T 细胞的不同耗竭状态。确定了三个与 T 细胞耗竭相关的基因(RAD23A、SAC3D1、PSIP1),并用于构建 T 细胞耗竭模型。该模型对 OS 预后具有强大的预测能力,低 TEX 评分组的患者预后更好,免疫细胞浸润增加,对治疗的反应性更高,而高 TEX 评分组的患者则相反。
结论:总之,我们的研究阐明了 T 细胞耗竭在 OS 免疫治疗和进展中的作用,基于 T 细胞耗竭相关基因构建的预后模型有望成为 OS 患者管理和治疗中预测的一种潜在方法。
Cancer Immunol Immunother. 2024-1-27
Cancer Biother Radiopharm. 2024-9
Exp Biol Med (Maywood). 2023-1
World J Gastrointest Oncol. 2025-7-15
Front Immunol. 2025-3-18
Front Pharmacol. 2025-2-25
Mol Ther Nucleic Acids. 2024-12-5
Cancers (Basel). 2023-5-11
Signal Transduct Target Ther. 2023-6-19
Biochim Biophys Acta Mol Basis Dis. 2023-8
Cancers (Basel). 2022-12-30
Sci Transl Med. 2022-11-9